|
DGCR11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.648600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.192400E-01 |
| Normal-vs-Stage2 |
4.319400E-01 |
| Normal-vs-Stage3 |
5.395000E-01 |
| Normal-vs-Stage4 |
8.702400E-01 |
| Stage1-vs-Stage2 |
4.197400E-01 |
| Stage1-vs-Stage3 |
4.662400E-01 |
| Stage1-vs-Stage4 |
8.054000E-01 |
| Stage2-vs-Stage3 |
8.199200E-01 |
| Stage2-vs-Stage4 |
5.711400E-01 |
| Stage3-vs-Stage4 |
7.098200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.889400E-01 |
| Normal-vs-AfricanAmerican |
1.152200E-01 |
| Normal-vs-Asian |
9.091800E-01 |
| Caucasian-vs-AfricanAmerican |
5.115500E-02 |
| Caucasian-vs-Asian |
9.650200E-01 |
| AfricanAmerican-vs-Asian |
1.325630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.786600E-01 |
| Normal-vs-Female |
7.506000E-01 |
| Male-vs-Female |
9.322800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.618400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.817000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.214400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.760800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.813800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.637580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.635000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.582600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.130400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.956600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.019550E-01 |
| Classical-VS-Follicular |
2.212200E-04 |
| Classical-VS-Other |
2.028200E-01 |
| Classical-VS-Normal |
2.435800E-01 |
| Tall-VS-Follicular |
9.579600E-02 |
| Tall-VS-Other |
3.145600E-01 |
| Tall-VS-Normal |
4.816200E-01 |
| Follicular-VS-Other |
9.345800E-01 |
| Follicular-VS-Normal |
6.483200E-03 |
| Other-VS-Normal |
1.197590E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.085600E-02 |
| Normal-vs-N1 |
8.910000E-01 |
| N0-vs-N1 |
2.723200E-01 |
|
|
